Correlation of R2 with total iron concentration in the brains of rhesus monkeys

Journal of Magnetic Resonance Imaging

Volumn 21, Issue 2, 2005, Pages 118-127

  Hardy, Peter A ^a,c   Gash, Don ^b   Yokel, Robert ^c   Andersen, Anders ^b   Ai, Yi ^b   Zhang, Zhiming ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Iron; Magnetic resonance imaging; Parkinson's disease; Rhesus monkeys; T2

Indexed keywords

FERRITIN; IRON;

AGING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BRAIN; CALCULATION; CORRELATION ANALYSIS; ECHO PLANAR IMAGING; ELECTRON SPIN RESONANCE; EUTHANASIA; FEMALE; GLOBUS PALLIDUS; GRAY MATTER; HISTOPATHOLOGY; IMAGE ANALYSIS; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PRIORITY JOURNAL; RELAXATION TIME; RHESUS MONKEY; SENSITIVITY ANALYSIS; SUBSTANTIA NIGRA;

AGING; ANIMALS; BRAIN CHEMISTRY; CEREBELLUM; FEMALE; FERRITINS; GLOBUS PALLIDUS; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; IRON; MACACA MULATTA; MAGNETIC RESONANCE IMAGING; SPECTROPHOTOMETRY, ATOMIC; SUBSTANTIA NIGRA;

EID: 12744280693     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.20244     Document Type: Article

References (37)

1. Koeppen AH. The history of iron in the brain. J Neurol Sci 1995;134(Suppl):1-9.
2. Buettner GR, Jurkiewicz BZ. Catalytic metals, ascorbate, and free radicals: combinations to avoid. Radiat Res 1996;145:532-541.
3. Eaton JW, Qian M. Molecular bases of cellular iron toxicity. Free Radic Biol Med 2002;32:833-840.
4. Sofic E, Riederer P, Heinsen H, et al. Increased iron (III) and total iron content in postmortem substantia nigra of parkinsonian brain. J Neural Transm 1988;74:199-205.
5. Youdim MB. Iron in the brain: implications for Parkinson's and Alzheimer's diseases. Mt Sinai J Med 1988;55:97-101.
6. Jellinger KA. The role of iron in neurodegeneration: prospects for pharmacotherapy of Parkinson's disease. Drugs Aging 1999;14:115-140.
7. Dexter DT, Carayon A, Javoy Agid F, et al. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain 1991;114:1953-1975.
8. Bartzokis G, Cummings J, Perlman S, et al. Increased basal ganglia iron levels in Huntington disease. Arch Neurol 1999;56:569-574.
9. Connor JR, Menzies SL, St. Martin SM, et al. A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains. J Neurosci Methods 1992;31:75-83.
10. Gerlach M, Ben Shachar D, Riederer P, et al. Altered brain metabolism of iron as a cause of neurodegenerative diseases? J Neurochem 1994;63:793-807.
11. Brittenham GM, Badman DG. Noninvasive measurement of iron: report of an NIDDK workshop. Blood 2003;101:15-19.
12. Drayer BP. Magnetic resonance imaging and extrapyramidal movement disorders. Eur Neurol 1989;29(Suppl 1):9-12.
13. Chen J, Hardy PA, Clauberg M, et al. T2 values in the human brain: comparison with quantitative assays of iron and ferritin. Radiology 1989;173:521-526.
14. Liu P, Henkelman R, Joshi J, et al. Quantification of cardiac and tissue iron by nuclear magnetic resonance relaxometry in a novel murine thalassemia-cardiac iron overload model. Can J Cardiol 1996;12:155-164.
15. Gelman N, Gorell JM, Barker PB, et al. MR imaging of human brain at 3.0 T: preliminary report on transverse relaxation rates and relation to estimated iron content. Radiology 1999;210:759-767.
16. Gelman N, Ewing JR, Gorell JM, et al. Interregional variation of longitudinal relaxation rates in human brain at 3.0 T: relation to estimated iron and water contents. Magn Reson Med 2001;45:71-79.
17. Ogg RJ, Steen RG. Age-related changes in brain T1 are correlated with iron concentration. Magn Reson Med 1998;40:749-753.
18. Hallgren B, Sourander P. The effect of age on the non-haemin iron in the human brain. J Neurochem 1958;3:41-51.
19. Andersen A, Zhang Z, Zhang M, et al. Age-associated changes in rhesus CNS composition identified by MRI. Brain Res 1999;829:90-98.
20. Matlab. The MathWorks, Inc. Natick, MA.
21. IDL. Research Systems, Inc. Boulder, CO.
22. Henkelman RM. Measurement of signal intensities in the presence of noise in MR images. Med Phys 1984;12:232-233.
23. Armitage P, Berry G. Statistical methods in medical research. Oxford: Blackwell Science, Ltd.; 1994. 207 p.
24. Ai Y, Zhang Z, Andersen A, et al. Iron accumulation, increasing substantia nigra pathology and motor function decline in aging rhesus monkeys. Soc Neurosci 2000;873:1.
25. Yokel RA, Fredenburg AM, Durbin PW, et al. The hexadentate hydroxypyridinonate TREN-(Me-3,2-HOPO) is a more orally active iron chelator than its bidentate analogue. J Pharm Sci 2000;89:545-555.
26. Zhang ZM, Smith GA, Gerhardt GA, et al. Motor slowing and parkinsonian signs in aging rhesus monkeys mirror human aging. J Gerontol Biol Sci 2000;55A:B473-B480.
27. Chen J, Hardy P, Kucharczyk W, et al. MR of human postmortem brain tissue: correlative study between T2 and assays of iron and ferritin in Parkinson and Huntington disease. AJNR Am J Neuroradiol 1993;14:275-281.
28. Connor JR, Boeshore KL, Benkovic SA, et al. Isoforms of ferritin have a specific cellular distribution in the brain. J Neurosci Methods 1994;37:461-465.
29. Casey JL, Hentze MW, Koeller DM, et al. Iron responsive elements regulate RNA sequences that control mRNA levels and translation. Science 1988;240:924-928.
30. Schenck JF. Imaging of brain iron by magnetic resonance: T2 relaxation at different field strengths. J Neurol Sci 1995;134:8.
31. Bartzokis G, Cummings JL, Markham CH, et al. MRI evaluation of brain iron in earlier- and later-onset Parkinson's disease and normal subjects. Magn Reson Imaging 1999;17:213-222.
32. Vymazal J, Hajek M, Patronas N, et al. The quantitative relation between T1-weighted and T2-weighted MRI of normal gray matter and iron concentration. J Magn Reson Imaging 1995;5:554-560.
33. Morris CM, Candy JM, Keith AB, et al. Brain iron homeostasis. J Inorg Biochem 1992;47:257-265.
34. Hill JM. The distribution of iron in the brain. In: Youdim MBH, editor. Brain iron: neurochemical and behavioural aspects. New York: Taylor & Francis: 1988. p 1-24.
35. Zecca L, Gallorini M, Schunemann V, et al. Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes. J Neurochem 2001;76:1766-1773.
36. Ye FQ, Martin WR, Allen PS. Estimation of brain iron in vivo by means of the interecho time dependence of image contrast. Mag Reson Med 1996;36:153-158.
37. Grabill C, Silva AC, Smith SS, et al. MRI detection of ferritin iron overload and associated neuronal pathology in iron regulatory protein-2 knockout mice. Brain Res 2003;971:95-106.